StockWatch
·
Healthcare Research- Analytics & Technology
Management Change13 Aug 2026, 11:20 pm

Bilcare Appoints Mohan Bhandari, Reappoints Kavita Bhansali as Directors

AI Summary

Bilcare Limited announced significant board changes following a meeting on August 13, 2026. Mr. Mohan Bhandari has been appointed as an Executive Director, subject to member approval. Ms. Kavita Bhansali has been reappointed as an Executive Director for a further five-year term, also pending member approval. The company also reported its unaudited financial results for the quarter ended June 30, 2026, showing revenue from operations at ₹1.94 Crores. Additionally, Mr. Sagar R. Baheti resigned as Company Secretary and Compliance Officer, with Mr. Mayur Dave appointed to these roles. The company also proposed the voluntary winding up of its wholly-owned US subsidiary, Bilcare INC, which is not considered a material subsidiary.

Key Highlights

  • Mohan Bhandari appointed Executive Director; Kavita Bhansali reappointed.
  • Unaudited Q1 FY27 results show revenue from operations at ₹1.94 Cr.
  • Mayur Dave appointed Company Secretary and Compliance Officer.
  • Proposal to voluntarily wind up US subsidiary, Bilcare INC.
  • All appointments are subject to shareholder approval.